HIGHRegulatoryTier 1
Dental Sleep Medicine Experts Call on the FDA to Protect Consumers
SourceDecisions in DentistryTier 1Clinical & Visual
By Kristen Pratt Machado
Originally at decisionsindentistry.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Dental practices that offer oral appliance therapy for sleep apnea face rising compliance risk and revenue loss if patients purchase unverified over-the-counter devices; practice owners and sleep-medicine dentists should prepare for possible new FDA consumer guidance that reinforces the prescription requirement.
Key points
- The American Academy of Dental Sleep Medicine sent a letter to FDA Office of Product Evaluation and Quality Director Owen Faris requesting a dedicated FDA webpage on oral appliances for obstructive sleep apnea.
- The AADSM letter cites the FDA’s existing clear-aligner webpage as a model for advising consumers to seek licensed care.
- The AADSM warns that micro-CPAP nostril inserts, boil-and-bite mouthguards, and other over-the-counter anti-snoring products lack evidence of efficacy and may cause harm.
- More than 80 million U.S. adults are estimated to have obstructive sleep apnea, underscoring the potential market scope for prescription oral appliances.
Who should care
OwnerSpecialistAssociate
Read the original on Decisions in Dentistry
Full reporting and any paywall content live on decisionsindentistry.com. We summarize and score; we do not republish.